Go Deep
TransMedics Group, Inc.
TransMedics Group, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,548 | 20.2 | 5.21 | 1.68 | 7,521.34 |
| Oct 2026 | 18,491 | 20.3 | 5.23 | 1.68 | 7,484.04 |
| Oct 2026 | 19,265 | 20.5 | 5.30 | 1.68 | 7,536.32 |
| Oct 2026 | 19,503 | 19.6 | 5.05 | 1.68 | 7,170.43 |
| Oct 2026 | 19,436 | 20.8 | 5.12 | 1.68 | 7,266.42 |
| Oct 2026 | 19,815 | 18.3 | 4.74 | 1.68 | 6,703.92 |
| Oct 2026 | 19,761 | 18.5 | 4.79 | 1.68 | 6,788.85 |
| Oct 2026 | 19,554 | 19.4 | 5.00 | 1.68 | 7,087.52 |
| Oct 2026 | 19,708 | 18.8 | 4.85 | 1.68 | 6,847.75 |
| Oct 2026 | 19,731 | 18.7 | 4.82 | 1.68 | 6,801.80 |
| Oct 2026 | 19,818 | 18.3 | 4.74 | 1.68 | 6,704.89 |
TransMedics Group, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 189,948,000.0 | 173,933,000.0 | 160,764,000.0 | 143,823,000.0 |
| Net Profit | 14,682,000.0 | 7,315,000.0 | 105,383,000.0 | 24,319,000.0 |
| EPS | 0.4 | 0.2 | 3.1 | 0.7 |
TransMedics Group, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 605,494,000.0 | 441,540,000.0 | 241,623,000.0 | 93,459,000.0 | — |
| Net Profit | 190,291,000.0 | 35,464,000.0 | -25,028,000.0 | -36,231,000.0 | — |
| EPS | 5.6 | 1.1 | -0.8 | -1.2 | — |
TransMedics Group, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 1,068,373,000.0 | 804,076,000.0 | 706,047,000.0 | 277,147,000.0 | — |
| Total Liabilities | 595,273,000.0 | 575,473,000.0 | 568,845,000.0 | 89,772,000.0 | — |
| Total Equity | 473,100,000.0 | 228,603,000.0 | 137,202,000.0 | 187,375,000.0 | — |
Owes vs Owns
TransMedics Group, Inc. owed $0.65 for every $1 it owned in Jun 2026, up from $0.32 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.65× | 0.56× | 0.72× | 0.81× | 0.32× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
TransMedics Group, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 45.7%Receivables 7.9%Inventory 4.6%Fixed assets (tangible) 31.2%Intangible assets 1.3%Other assets 9.4%
How it's funded — Dec 2025
Short-term debt 0.9%Long-term debt 47.0%Payables 1.0%Other liabilities 6.8%Shareholders' equity 44.3%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 488.4 | 336.6 | 394.8 | 201.2 |
| Receivables | 84.3 | 97.7 | 63.6 | 27.6 |
| Inventory | 48.9 | 46.6 | 44.2 | 20.6 |
| Fixed assets (tangible) | 332.8 | 292.5 | 180.5 | 24.4 |
| Intangible assets | 13.5 | 13.7 | 14.3 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 100.5 | 17.0 | 8.6 | 3.4 |
| Liabilities & equity | ||||
| Short-term debt | 10.0 | 2.7 | 2.0 | 1.4 |
| Long-term debt | 502.4 | 509.3 | 506.2 | 58.7 |
| Payables | 10.3 | 10.3 | 12.7 | 3.3 |
| Other liabilities | 72.5 | 53.1 | 47.9 | 26.3 |
| Shareholders' equity | 473.1 | 228.6 | 137.2 | 187.4 |
| Net tangible assets | 459.6 | 214.9 | 122.9 | 187.4 |
TransMedics Group, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 192,840,000.0 | 48,803,000.0 | -13,028,000.0 | -45,817,000.0 | — |
| Investing Activities | -59,251,000.0 | -129,303,000.0 | -193,953,000.0 | 54,513,000.0 | — |
| Financing Activities | 16,857,000.0 | 22,874,000.0 | 400,418,000.0 | 167,927,000.0 | — |